EUVIMEDEUVIMED entdecken
Crossref

Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens

Ana Julia S Moreira, Katialaine C de Araújo Domingues, Karine D V Camargo, Nicole A Aulik, Linda B Oyama, Sharon A Huws, Hilario C Mantovani iD

Journal of Antimicrobial Chemotherapy · 03.02.2025 · 80 (2) · 427-438

DOI: 10.1093/jac/dkae425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 25.11.2024. Verfasst von Ana Julia S Moreira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Universidade Federal de Viçosa, Viçosa, MG, Brazil. Hauptthemen laut MEDLINE: Mastitis, Bovine, Edetic Acid, Drug Synergism, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Wisconsin Dairy Innovation Hub, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bovine mastitis is the costliest disease in the dairy sector and the main cause of antibiotic use in dairy cattle, potentially contributing to the antimicrobial resistance crisis. Antimicrobial peptides (AMPs) offer promise as antibiotic alternatives for controlling mastitis pathogens.

Methods

The efficacy of five AMPs (Lynronne-1 [Lyn-1], Lynronne-2 [Lyn-2], Bovicin HC5, AMP 660, and AMP 1043) and two bioactive compounds (disodium ethylenediaminetetraacetic acid [EDTA] and glycerol monolaurate) was assessed against a range of 35 mastitis-causing pathogens. The fractional inhibitory concentrations index (FICI) was calculated to determine the interaction effect and values ≤0.5 were indicative of synergism. Time-dependent killing assays were performed to assess bactericidal efficacy of the combination. Cytotoxicity was evaluated using the MTT assay and haemolytic activity was assessed against fresh bovine erythrocytes.

Results

Lyn-1 and EDTA exhibited the highest broad spectrum antimicrobial activity and reduced bacterial growth (OD600 nm) by 95.1% and 86.9%, respectively. FICI values ranged from 0.1 to 0.5, indicating synergism. The combination of lyn-1 (0.03 mg/mL) and EDTA (1.02 mg/mL) exhibited higher antimicrobial activity against all bacterial strains, at significantly lower concentrations than each compound individually. Lyn-1-EDTA combination reduced viable population by >10 000-fold within 12 h. The combination was non-haemolytic in concentrations up to 8-fold the established MIC values (P > 0.05), although cytotoxic effects were observed at concentrations above MIC (P < 0.01).

Conclusions

These findings highlight the therapeutic potential of Lyn-1 and Lyn-1-EDTA for developing antibiotic-free formulations to combat contagious and environmental mastitis pathogens and treat udder infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastitis, BovineEdetic AcidDrug SynergismAnti-Bacterial AgentsBacteriaAntimicrobial PeptidesAnti-Infective AgentsAnimalsCattleFemaleMicrobial Sensitivity TestsErythrocytesMicrobial ViabilityHemolysis

Substanzen

Edetic AcidAnti-Bacterial AgentsAntimicrobial PeptidesAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Microbiology, Universidade Federal de Viçosa, Viçosa, MG, Brazil.
  • Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Animal Science, Universidade Estadual Paulista, Jaboticabal, SP, Brazil.
  • Wisconsin Veterinary Diagnostic Laboratory, University of Wisconsin-Madison, Madison, WI, USA.
  • Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.

ORCID-Profile: Hilario C Mantovani

Förderung

  • Wisconsin Dairy Innovation Hub
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

Moreira, A. J. S., de Araújo Domingues, K. C., Camargo, K. D. V., Aulik, N. A., Oyama, L. B., Huws, S. A., & Mantovani, H. C. (2025). Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens. Journal of Antimicrobial Chemotherapy, 80(2), 427-438. https://doi.org/10.1093/jac/dkae425

Vancouver

Moreira AJS, de Araújo Domingues KC, Camargo KDV, Aulik NA, Oyama LB, Huws SA, et al. Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens. Journal of Antimicrobial Chemotherapy. 2025;80(2):427-438. doi:10.1093/jac/dkae425

BibTeX
@article{Moreira2025,
  author = {Moreira, Ana Julia S and de Araújo Domingues, Katialaine C and Camargo, Karine D V and Aulik, Nicole A and Oyama, Linda B and Huws, Sharon A and Mantovani, Hilario C},
  title = {Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {2},
  pages = {427--438},
  doi = {10.1093/jac/dkae425}
}
Kostenlos starten →